Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 1
2012 2
2016 1
2017 5
2018 1
2019 2
2020 1
2021 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Loomba R, Harrison SA, Balabanska R, Mateva L, Lanthier N, Alkhouri N, Moreno C, Schattenberg JM, Stefanova-Petrova D, Vonghia L, Rouzier R, Guillaume M, Hodge A, Romero-Gómez M, Huot-Marchand P, Baudin M, Richard MP, Abitbol JL, Broqua P, Junien JL, Abdelmalek MF; NATIVE Study Group. Francque SM, et al. N Engl J Med. 2021 Oct 21;385(17):1547-1558. doi: 10.1056/NEJMoa2036205. N Engl J Med. 2021. PMID: 34670042 Clinical Trial.
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.
Abu-Khalaf MM, Alex Hodge K, Hatzis C, Baldelli E, El Gazzah E, Valdes F, Sikov WM, Mita MM, Denduluri N, Murphy R, Zelterman D, Liotta L, Dunetz B, Dunetz R, Petricoin EF, Pierobon M. Abu-Khalaf MM, et al. Among authors: alex hodge k. NPJ Precis Oncol. 2023 Feb 16;7(1):18. doi: 10.1038/s41698-023-00360-5. NPJ Precis Oncol. 2023. PMID: 36797347 Free PMC article.
Antibody Validation by Western Blotting.
Signore M, Manganelli V, Hodge A. Signore M, et al. Among authors: hodge a. Methods Mol Biol. 2017;1606:51-70. doi: 10.1007/978-1-4939-6990-6_4. Methods Mol Biol. 2017. PMID: 28501993
Reverse Phase Protein Microarrays.
Baldelli E, Calvert V, Hodge A, VanMeter A, Petricoin EF 3rd, Pierobon M. Baldelli E, et al. Among authors: hodge a. Methods Mol Biol. 2017;1606:149-169. doi: 10.1007/978-1-4939-6990-6_11. Methods Mol Biol. 2017. PMID: 28502000
Endogenous Gastrin Collaborates With Mutant KRAS in Pancreatic Carcinogenesis.
Nadella S, Burks J, Huber M, Wang J, Cao H, Kallakury B, Tucker RD, Boca SM, Jermusyck A, Collins I, Vietsch EE, Pierobon M, Hodge KA, Cui W, Amundadottir LT, Petricoin E 3rd, Shivapurkar N, Smith JP. Nadella S, et al. Among authors: hodge ka. Pancreas. 2019 Aug;48(7):894-903. doi: 10.1097/MPA.0000000000001360. Pancreas. 2019. PMID: 31268978
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.
Baldelli E, Hodge KA, Bellezza G, Shah NJ, Gambara G, Sidoni A, Mandarano M, Ruhunusiri C, Dunetz B, Abu-Khalaf M, Wulfkuhle J, Gallagher RI, Liotta L, de Bono J, Mehra N, Riisnaes R, Ravaggi A, Odicino F, Sereni MI, Blackburn M, Zupa A, Improta G, Demsko P, Crino' L, Ludovini V, Giaccone G, Petricoin EF, Pierobon M. Baldelli E, et al. Among authors: hodge ka. J Immunother Cancer. 2021 Oct;9(10):e002179. doi: 10.1136/jitc-2020-002179. J Immunother Cancer. 2021. PMID: 34620701 Free PMC article.
21 results